Two companies benefitting from the Middle East war
As the share market gyrates around the expected impact of the Iran War, a small group of companies are experiencing a benefit. Here are two more such situations.
Stock picks from our team of market veterans.
As the share market gyrates around the expected impact of the Iran War, a small group of companies are experiencing a benefit. Here are two more such situations.
Here are stocks the market appears to think could benefit from the Middle East fiasco. Here are two such cases.
Michael Gable, Managing Director of Fairmont Equities, says he continues to believe we're seeing the start of a commodities bull market and investors can do well to rotate away from high P/E stocks, such as tech, and into hard assets, like Rio Tinto (RIO).
Does the 'gold and guns' trade still have legs and is it a prime contrarian play to take advantage of current market weakness? Here's my view, with caveats.
In our "HOT" stock article, Michael Gable, Managing Director of Fairmont Equities, says that the charts show that any upside for the share price of Santos (STO) could be significant and a dip in the short term could provide a buying opportunity.
In our “HOT” stock article, Michael Gable, Managing Director of Fairmont Equities, says that Coronado Coal (CRN) appears ready to head higher again as higher oil and gas prices will likely spill over into higher demand for coal.
What are your thoughts on “momentum” ETFs? When does the entitlement offer for WCM Global Growth (WQG) close? Is the takeover offer for Qube still alive? Do the broker analysts think there is upside for high yielder Suncorp?
Let's see how accurate the saying "don't try to catch the falling knife" applies to these growth stocks: Xero, Pro Medicus and JB Hi-Fi. Am I ready to buy them at current prices?
It’s hard to concentrate on individual stocks when some urgers are calling the Iran war the start of World War III. Today I want to look at the big picture outlook and what ETFs might be smart plays when battening down the hatches makes sense.
In our “HOT” stock column today, Raymond Chan, Adviser and Head of Asian Desk at Morgans explains why the view on Sigma Healthcare (SIG) is to accumulate.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.